ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,561.12
0.93%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Genelabs Technologies (MM) (GNLB)

  7. Genelabs Technologies (MM) (GNLB) Noticias

GNLB

Genelabs (GNLB)

Genelabs Technologies (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:GNLB
FechaHoraFuenteTítuloSímboloCompañía
07/01/200916:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
07/01/200915:46Edgar (US Regulatory)(25-NSE)NASDAQ:GNLBGenelabs Technologies (MM)
07/01/200912:34Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:GNLBGenelabs Technologies (MM)
07/01/200907:59Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:GNLBGenelabs Technologies (MM)
07/01/200907:50PR Newswire (US)GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
30/12/200807:50PR Newswire (US)GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.NASDAQ:GNLB
15/12/200808:00PR Newswire (US)GlaxoSmithKline Further Extends Tender Offer to Acquire Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
08/12/200808:11PR Newswire (US)GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
05/12/200809:50Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:GNLBGenelabs Technologies (MM)
03/12/200815:30PR Newswire (US)GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
20/11/200805:00Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:GNLBGenelabs Technologies (MM)
13/11/200815:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:GNLBGenelabs Technologies (MM)
13/11/200813:37Business WireGenelabs Reports Results for the Third Quarter and First Nine Months of 2008NASDAQ:GNLBGenelabs Technologies (MM)
13/11/200813:12Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:GNLBGenelabs Technologies (MM)
12/11/200814:47Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:GNLBGenelabs Technologies (MM)
12/11/200814:33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/A)NASDAQ:GNLBGenelabs Technologies (MM)
12/11/200811:01Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:GNLBGenelabs Technologies (MM)
12/11/200810:54Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:GNLBGenelabs Technologies (MM)
12/11/200808:44PR Newswire (US)GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc.NASDAQ:GNLBGenelabs Technologies (MM)
05/11/200816:30Edgar (US Regulatory)Amended Quarterly Report (10-Q/A)NASDAQ:GNLBGenelabs Technologies (MM)
05/11/200816:30Edgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:GNLBGenelabs Technologies (MM)
04/11/200814:29Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:GNLBGenelabs Technologies (MM)
31/10/200808:00PR Newswire (US)Beacon Equity Issues Technical Trade Alerts on Market Movers: GNLB, SPSN, PDGI, SIMO, UCTT, CYCLNASDAQ:GNLBGenelabs Technologies (MM)
30/10/200815:53Edgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:GNLBGenelabs Technologies (MM)
30/10/200805:01Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:GNLBGenelabs Technologies (MM)
29/10/200819:44PR Newswire (US)GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis CNASDAQ:GNLBGenelabs Technologies (MM)
09/10/200811:15Business WireGenelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at the 15th International Sym...NASDAQ:GNLBGenelabs Technologies (MM)
07/10/200815:15Edgar (US Regulatory)Genelabs Technologies Inc /Ca - Current report filing (8-K)NASDAQ:GNLBGenelabs Technologies (MM)
03/10/200816:01Edgar (US Regulatory)Genelabs Technologies Inc /Ca - Statement of Changes in Beneficial Ownership (4)NASDAQ:GNLBGenelabs Technologies (MM)
18/09/200806:23Edgar (US Regulatory)Genelabs Technologies Inc /Ca - Amended Statement of Ownership (SC 13G/A)NASDAQ:GNLBGenelabs Technologies (MM)
 Showing the most relevant articles for your search:NASDAQ:GNLB

Su Consulta Reciente

LSE
HHPG
Hon Hai 144a
COIN
BOSONGBP
Boson Token
BIT
F36221
Vontobel Financial Produ...
NASDAQ
AAZUUXX
Gs Finance Corp Autocall...
EU
LVO
Amundi S&P 500 VIX Futur...
LBNK
SASUSDT
Smart Aliens
NYSE
ENPC.WS
Executive Network Partne...
COIN
GOLDUCKETH
Golden Duck
NASDAQ
OPHCD
TG
HSY
Hershey
OKEX
CELBTC
Celsius
EU
SANAF
Sanofi Aventis 1.125% 05...
USOTC
KYHHY
Kyushu Ry (PK)
USOTC
OPSSF
Opsens (QX)
COIN
HAMSUSD
Hamsters
USOTC
MBST
Mobile Star (CE)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados